Open access · CC-BY
via OpenAlex
Fisetin in malignant nervous system tumors: molecular insights and translational advances
Exploration of neuroscience · 2026
Deregulated nutrient-sensing
Altered intercellular communication
Senolytics
Cell culture / in vitro
Human
Preclinical / animal
In vitro
Abstract
Malignant tumors of the nervous system, such as gliomas, medulloblastomas, and neuroblastomas, pose a greater clinical challenge due to their aggressive and invasive nature and their resistance to current treatment options. The blood-brain barrier (BBB) impairs the delivery of therapeutic agents, which is associated with poor prognosis. The natural flavonoid fisetin has demonstrated potential for cancer treatment by regulating major cancer-related signaling pathways, including PI3K/Akt/mTOR(definition), NF-κB, and MAPK. Preclinical studies suggest that fisetin induces apoptosis, suppresses tumor invasion, and reduces malignancy in glioma, medulloblastoma, and neuroblastoma models. However, evidence for fisetin’s effectiveness remains preclinical and in vitro, with no clinical trials in humans to date. One solution to this challenge is to use nanotechnology-based delivery systems to increase fisetin’s stability and solubility and facilitate its crossing of the BBB, thereby enhancing its therapeutic efficacy. Such advancements have made fisetin a promising option for neuro-oncology treatment. Further clinical trials are needed to assess the safety, efficacy, and effectiveness of fisetin in combination therapies. When conjugated with nanotechnology-based delivery, fisetin may enable a digital transformation in treatment outcomes for patients with malignant nervous system tumors.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.37349/en.2026.1006130
- Canonical
- link ↗
- Fetched
- 2026-10-12 MST
Cite this
APA
Kumar, A., & Amita (2026). Fisetin in malignant nervous system tumors: molecular insights and translational advances. <em>Exploration of neuroscience</em>. https://doi.org/10.37349/en.2026.1006130
Vancouver
Kumar A, Amita. Fisetin in malignant nervous system tumors: molecular insights and translational advances. Exploration of neuroscience. 2026. doi:10.37349/en.2026.1006130.
BibTeX
@article{ajay2026Fiseti,
title = {Fisetin in malignant nervous system tumors: molecular insights and translational advances},
author = {Ajay Kumar and Amita},
journal = {Exploration of neuroscience},
year = {2026},
doi = {10.37349/en.2026.1006130},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nutrients 2016
Open access · CC-BY
Nutritional Deficiency in Patients with Heart Failure
Stem Cell Research & Therapy 2025
Open access · CC-BY
The role of the mTOR pathway in breast cancer stem cells (BCSCs): mechanisms and therapeutic potentials
Molecular biology reports 2026
Citation only
Musculoskeletal degeneration and cardiovascular aging: a narrative review of shared mechanobiological pathways.
Current Neuropharmacology 2016
Open access · OA
Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
Frontiers in Immunology 2019
Open access · CC-BY
Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
Signal Transduction and Targeted Therapy 2023
Open access · CC-BY